0001493152-24-022029.txt : 20240530 0001493152-24-022029.hdr.sgml : 20240530 20240530180006 ACCESSION NUMBER: 0001493152-24-022029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aminov Erez CENTRAL INDEX KEY: 0001986112 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 241006954 MAIL ADDRESS: STREET 1: C/O MIRA PHARMACEUTICALS, INC. STREET 2: 900 WEST PLATT STREET, SUITE 200 CITY: TAMPA STATE: FL ZIP: 33606-2173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 1200 BRICKELL AVENUE STREET 2: SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 4 1 ownership.xml X0508 4 2024-05-28 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0001986112 Aminov Erez C/O MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVE. SUITE 1950 #1183 MIAMI FL 33131 1 1 0 0 Chief Executive Officer 0 Incentive Stock Options (right to buy) 0.84 2024-05-28 4 A 0 379000 0 A 2034-05-28 Common Stock 379000 629000 D The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024. The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024. Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each. /s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov 2024-05-30